• Теги
    • избранные теги
    • Компании2375
      • Показать ещё
      Разное608
      • Показать ещё
      Страны / Регионы376
      • Показать ещё
      Люди148
      • Показать ещё
      Международные организации25
      • Показать ещё
      Формат38
      Издания69
      • Показать ещё
      Показатели32
      • Показать ещё
      Сферы1
Выбор редакции
Выбор редакции
15 сентября, 20:56

U.S. senator slams Allergan patent deal with Native-American tribe

Brown's staff has requested a meeting with Allergan representatives to press them about the transaction. Allergan said on Sept. 8 it will transfer patents relating to its dry-eye medicine Restasis to the Saint Regis Mohawk Tribe, which will exclusively license them back to the company in exchange for ongoing payments.

15 сентября, 17:33

Amgen/Allergan's Avastin Biosimilar Secures FDA Approval

The FDA approves Amgen-Allergan's biosimilar version of Roche's Avastin for treating multiple types of cancers, to be marketed by the trade name of Mvasi.

15 сентября, 13:52

Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO

Key highlights this week include Teva's (TEVA) CEO announcement and the FDA approval of the first cancer biosimilar.

Выбор редакции
14 сентября, 22:05

Amgen and Allergan say FDA has approved biosimilar of Roche's Avastin

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

14 сентября, 18:12

AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs

AstraZeneca (AZN) recently sold its remaining rights to its anaesthetics medicines to Aspen Group for an upfront consideration of $555 million.

13 сентября, 15:33

Biotech Stock Roundup: Alexion to Cut Jobs, Streamline Operations, Kura Up on Cancer Data

Key highlights include Alexion's (ALXN) restructuring plans and promising data from Kura Oncology on its lead pipeline candidate.

Выбор редакции
Выбор редакции
12 сентября, 05:12

U.S. tribal patent deal could have big impact on generic drug market

(Reuters) - A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be used be to protect them from challenges in federal court, legal experts said, potentially dealing a blow to generic competition.

Выбор редакции
12 сентября, 01:51

Cramer's lightning round: Allergan's in a torturous situation

Jim Cramer rattles off his take on callers' favorite stocks, including one hurting pharmaceutical name.

11 сентября, 18:59

Why Did Teva Pharmaceuticals Stock Soar Today?

Shares of Teva Pharmaceuticals (TEVA) opened more than 15% higher on Monday after the struggling drugmaker picked H. Lundbeck (HLUYY) chief Kare Schultz to fill its long-vacant CEO role.

11 сентября, 12:15

Why Is Aerie (AERI) Up 10% Since the Last Earnings Report?

Aerie (AERI) reported earnings more than a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

15 августа, 00:12

What David Tepper Bought And Sold In Q2: The Full Breakdown

Remember when several months ago the news that David Tepper disclosed that his Appaloosa bought a (tiny 100,000 share) take in Snapchat in Q1, sending the stock briefly higher, especially after he said that he would add more if the price fell below its IPO price of $17? Well, according to his just released 13F, he didn't, and in fact has since dissolved his entire stake in the company that has since pivoted to dancing hotdogs. That triviality aside, what was most notable about Tapper's Q2 holdings is that in addition to boosting several key tech names, as well as opening a new $500+ million position in Alibaba, he took his total long equity holdings to just over $6.7 billion as of June 30, up from $6.1 billion at the end of March, the highest net long exposure since September 2014. Here is a breakdown of the key position changes for Tepper as of March 31: Top new positions: Alibaba, QQQ ETF, IBB ETF, Dollar General, Stryker, Energy Transfer Equity, L Brands, Wells Fargo, Cemex, Top exits: Regions Financial, Pfizer, Mylan, Teva, Symantec, Charter, ArcelorMittal, United Continental, TerraForm, US Steel Boosted stakes: Micron, Google, Western Digital, Facebook, Apple, United Rentals, Thermo Fisher, UnitedHealth Group, Delta Airlines Cut stakes: Southwest, General Motors, Allergan, Kinder Morgan, Williams Partners, HCA, Nucor Steel, Boston Scientific, Mohawk Industries, PNC Financial And the full visual summary: bold are additions; green are new positions; Red are exits.

Выбор редакции
29 июня, 22:53

M&As, Rich Pipelines & Catalyst Rich 2017 to Drive Pharma Stocks

M&As, Rich Pipelines & Catalyst Rich 2017 to Drive Pharma Stocks

29 июня, 17:25

Sarepta Appoints Ex-Allergan Executive as CEO and President

Sarepta Therapeutics, Inc. (SRPT) announced the appointment of Douglas S. Ingram as the new chief executive officer (CEO).

29 июня, 16:30

Zacks Industry Outlook Highlights: Johnson & Johnson, Incyte, Pfizer, Novartis and AstraZeneca

Zacks Industry Outlook Highlights: Johnson & Johnson, Incyte, Pfizer, Novartis and AstraZeneca

Выбор редакции
27 июня, 17:26

Outline of Parnassus Fund (PARNX)

Parnassus Fund (PARNX) seeks long-term growth of capital

Выбор редакции
26 июня, 16:15

Allergan Continues to Focus on Acquisitions and Branded Unit

We issued an updated research report on Allergan plc (AGN) on Jun 23.

23 июня, 20:32

Top Stock Reports for Oracle, Allergan & Abbott

Top Stock Reports for Oracle, Allergan & Abbott

19 июня, 19:33

США объявили войну фармкомпаниям

Наркоторговцам в США объявлена война еще с 80-х гг., в результате чего правоохранительные органы крайне жестко работают с представителями этой отрасли криминального мира.